Infertility Treatment Market

Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure [ART (IVF, ICSI, Surrogate), Insemination, Laparoscopy, Tubal Ligation], Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Cryobanks) - Forecasts to 2023

Report Code: MD 3765 Nov, 2018, by marketsandmarkets.com

[176 Pages Report] The global infertility treatment market is expected to reach USD 2.2 billion by 2023 from USD 1.5 billion in 2018, at a CAGR of 8.0%. The study involved four major activities to estimate the current market size for infertility treatment. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and subsegments

Secondary Research

In the secondary research process, various secondary sources such as Hoovers, D&B, Bloomberg Business, and Factiva have been referred to, so as to identify and collect information for this study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold standard & silver standard websites, regulatory bodies, and databases.

Primary Research

The infertility treatment market comprises several stakeholders such as infertility treatment device manufacturers, medical device suppliers and distributors, healthcare service providers, and research laboratories. The demand side of this market is characterized by the increasing awareness among couples about the benefits of infertility treatment procedures and the growth in population. The supply side is characterized by advancements in technology. Various primary sources from both, the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. Following the breakdown of primary respondents

Infertility Treatment Market

To know about the assumptions considered for the study, download the pdf brochure

Data Triangulation

After arriving at the overall market size using the market size estimation processes as explained above the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both, the demand and supply sides, in the infertility treatment industry.

Report Objectives

  • To define, describe, and forecast the global market on the basis of procedure, product, patient type, end user, and region
  • To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing growth of the global market
  • To strategically analyze the micromarkets with respect to individual growth trends, future prospects, and contributions to the global market
  • To analyze the opportunities in the global market for key stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)
  • To profile the key players in the global market and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments, such as new product launches; agreements, partnerships, and collaborations; and acquisitions in the global market   

Scope of the report

Report Metric

Details

Market size available for years

2016-2023

Base year considered

2017

Forecast period

2018-2023

Forecast units

Value (USD)

Segments covered

Products, Procedure, Patient Type, End User, and Region

Geographies covered

North America (US & Canada), Europe (Germany, France, UK, RoE), APAC (Japan, China, India, RoAPAC), RoW (Latin America and the Middle East & Africa)

Companies covered

The Cooper Companies Inc. (US), Cook Group Incorporated (US), Vitrolife AB (Sweden), Hamilton Throne Ltd. (US). Major 15 players covered.

This research report categorizes the market based on product, procedure, patient type, end user, and region.

On the basis of Products, the infertility treatment market has been segmented as follows:

  • Equipment
    • Microscopes
    • Imaging Systems
    • Sperm Analyzer Systems
    • Ovum Aspiration Pumps
    • Micromanipulators Systems
    • Incubators
    • Gas Analyzers
    • Laser Systems
    • Cryosystems
  • Media & Consumables
  • Accessories

On the basis of Procedure, the infertility treatment market has been segmented as follows:

  • Assisted Reproductive Technology
    • In Vitro Fertilization
      • Intracytoplasmic morphologically-selected sperm injection (IMSI)
      • Gamete Donation
    • Intracytoplasmic Sperm Injection (ICSI)
    • Surrogacy
  • Artificial Insemination
    • Intrauterine Insemination
    • Intracervical Insemination
    • Intratubal Insemination
  • Fertility Surgery
    • Laparoscopy
    • Hysteroscopy
    • Myomectomy
    • Laparotomy
    • Tubal Ligation Reversal
    • Varicocelectomy
    • Microsurgical Reconstruction
      • Vasovasostomy
      • Vasoepididymostomy
  • Other Infertility Treatment Procedures

On the basis of Patient Type, the infertility treatment market has been segmented as follows:

  • Female Infertility Treatment
  • Male Infertility Treatment

On the basis of End User, the infertility treatment market has been segmented as follows:

  • Fertility Centers
  • Hospitals & Surgical Clinics
  • Cryobanks
  • Research Institutes

On the basis of Region, the infertility treatment market has been segmented as follows:

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • RoE
  • Asia Pacific
    • Japan
    • China
    • India
    • RoAPAC
  • Rest of the World
    • Latin America
    • Middle East & Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global infertility treatment market report:

Product Analysis

  • Product matrix which gives a detailed comparison of the product portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

The market for infertility treatment market is expected to grow from USD 1.5 billion in 2018 to USD 2.2 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 8.0% during the forecast period. Growth in the global market is primarily driven by factors such as the declining global fertility rate; rising number of fertility clinics worldwide; technological advancements; and increasing public-private investments, funds, and grants.

Infertility Treatment Market

By product, the media and consumables segment is expected grow at the highest rate during the forecast period

Commercially available culture media has various components, including nutrients, vitamins, and growth factors. The growth of this segment is attributed to the increasing awareness of infertility treatment and diagnosis globally. Another factor contributing to the market growth of this segment is the easy availability of different media and consumables across various regions.

By procedure, artificial insemination is expected to be the second largest contributor to the infertility treatment market

The key factors attributed to the large share of this segment include limited risk of complications during pregnancy and high success rate achieved by the couple. The artificial insemination market is subsegmented into three major types, namely, intrauterine insemination, intracervical insemination, and intratubal insemination. The intrauterine insemination segment holds the largest share in the artificial insemination segment. The growth of this market is attributed low risks of multiple births and with high number of live births.

By patient type, female infertility treatment is expected to hold the larger share in the infertility treatment market

Infertility is one of the common conditions diagnosed among women. The growing female infertility rates, availability of a variety of treatment options, increasing awareness among women about infertility treatments, and the growing number of fertility centers are the major factors contributing to the growth of this segment.

By end user, hospitals and surgical clinics are expected to second largest contributor to the infertility treatment market

Infertility treatments in hospitals are supported by other departments (such as neonatal intensive care units), and hospitals offer complete maternity treatment till childbirth. Initiatives undertaken by governments to increase the number of hospitals equipped to perform infertility treatment procedures such as IVF and the increasing number of surgical centers providing surgical options for the treatment of infertility is expected to drive the growth of this end user segment.

Infertility Treatment Market

North America is expected to hold a significant share in the infertility treatment market during the forecast period

Factors such as decreasing fertility rates, growing median age of first-time pregnancy, increase in healthcare expenditure, and presence of major players in this region (such as The Cooper Companies, Inc., Cook Group Incorporated, and Hamilton Throne Ltd.) are driving the growth of the infertility treatment market in North America.

The major vendors in the global market, The Cooper Companies Inc.  (US), Cook Group Incorporated (US), and Vitrolife AB (Sweden). Other prominent players operating in global market include Thermo Fisher Scientific, Inc. (US) Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato (Japan), Rocket Medical Plc (UK), IHMedical A/S (Denmark), Hamilton Throne Ltd. (US), MedGyn Products, Inc. (US), ZEISS Group (Germany), and SoMATEX Medical Technologies GmbH (Germany), among others.

Recent Developments

  • In March 2018, Vitrolife AB (Sweden) received approval for the sale of its time-lapse incubator EmbryoScope+ in the US. Through this the company expanded its product sale and market visibility in the US infertility treatment market.
  • In March 2018, Genea Limited (Australia) expanded its market presence in Melbourne by establishing a new fertility clinic in Melbourne
  • In April 2018, Baker Ruskinn (UK) entered into a partnership with I&L Biosystems UK Ltd. (UK) as its UK sales partner with the aim to expand its sales and distribution and strengthen its presence in the UK market

Key questions addressed by the report:

  • Which of the product segment will dominate the infertility treatment market in future?
  • Emerging countries have immense opportunities for the growth and adoption of infertility treatment, will this scenario continue in the next five years?
  • Where will all the advancements in products offered by various companies take the industry in the mid to long term?
  • Low procedural costs in the emerging market is impacting the growth for developed markets due to cost difference among procedures. How will pricing difference impact the overall market?
  • What are the upcoming procedures in the infertility treatment market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 18)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Geographic Scope
           1.3.3 Years Considered for the Study
    1.4 Currency
    1.5 Stakeholders

2 Research Methodology (Page No. - 22)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
           2.1.3 Market Size Estimation
                    2.1.3.1 Product-Based Market Estimation
           2.1.4 Primary Research Validation
    2.2 Market Breakdown and Data Triangulation
           2.2.1 Limitations
           2.2.2 Assumptions for the Study

3 Executive Summary  (Page No. - 32)

4 Premium Insights (Page No. - 36)
    4.1 Infertility Treatment Market: Overview
    4.2 Geographic Analysis: Market, By Product
    4.3 Asia Pacific: Market Share, By Procedure (2018)
    4.4 Market, By Patient Type, 2018 vs 2023 (USD Million)
    4.5 Market, By End User, 2018 vs 2023 (USD Million)
    4.6 Geographical Snapshot of the Global Market

5 Market Overview (Page No. - 41)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Declining Fertility Rate
                    5.2.1.2 Rising Number of Fertility Clinics Worldwide
                    5.2.1.3 Technological Advancements
                               5.2.1.3.1 Advancements in Infertility Treatment Devices
                               5.2.1.3.1 Increase in the Use of Time-Lapse Technology
                    5.2.1.4 Increasing Public-Private Investments, Funds, and Grants
           5.2.2 Restraints
                    5.2.2.1 High Procedural Cost of Assisted Reproductive Techniques in Developed Markets
                    5.2.2.2 Unsupportive Government Regulations
           5.2.3 Opportunities
                    5.2.3.1 Growth Opportunities in Emerging Markets
                               5.2.3.1.1 Improving Healthcare Infrastructure
                               5.2.3.1.2 Increasing Medical Tourism Due to Low Treatment Costs
                    5.2.3.2 Use of Fertility Treatment Options By Single Parents and Same-Sex Couples
           5.2.4 Challenges
                    5.2.4.1 Concerns Related to Art Procedures
                    5.2.4.2 Reduced Efficacy Among Older Women

6 Infertility Treatment Market, By Product (Page No. - 51)
    6.1 Introduction
    6.2 Equipment
           6.2.1 Microscopes
                    6.2.1.1 Growing Technological Advancements in the Field of Microscopy Resulting in the Growing Adoption of Microscopes
           6.2.2 Imaging Systems
                    6.2.2.1 Emergence of Time-Lapse Imaging Systems Driving the Growth of the Infertility Treatment Imaging Systems Market
           6.2.3 Sperm Analyzer Systems
                    6.2.3.1 Automated Sperm Analyzer Systems Permitting Internal and External Quality Control and Better Reproducibility
           6.2.4 Ovum Aspiration Pumps
                    6.2.4.1 Ovum Aspiration Pumps Enable Smooth Collection of Oocytes During Infertility Treatment Procedures
           6.2.5 Micromanipulator Systems
                    6.2.5.1 Micromanipulators are Commonly Used for the Treatment of Male Infertility, Particularly Cases Pertaining to Poor Sperm Quantity/Mobility
           6.2.6 Incubators
                    6.2.6.1 Incubators Play A Vital Role in Embryo Development and Improved Clinical Outcomes
           6.2.7 Gas Analyzers
                    6.2.7.1 Gas Analyzers Contain Multiple Ports Enabling Analysis of Sequential Gas Samples
           6.2.8 Laser Systems
                    6.2.8.1 The Common Applications of Laser Systems Include Treament of Stress Urinary Incontinence and Vaginal Tightening
           6.2.9 Cryosystems
                    6.2.9.1 Demand for Cryosystems is on the Rise as Women are Seeking to Extend Their Childbearing Years
    6.3 Media & Consumables
           6.3.1 Easy Availability of Culture Media Coupled With the Growing Awareness Among Individuals Driving the Growth of the Media & Consumables Segment
    6.4 Accessories
           6.4.1 Anti-Vibration Tables are Commonly Used for IVF Treatments to Provide A Smooth Workspace During Procedures

7 Infertility Treatment Market, By Procedure (Page No. - 65)
    7.1 Introduction
    7.2 Assisted Reproductive Technology
           7.2.1 in Vitro Fertilization
                    7.2.1.1 Intracytoplasmic Morphologically Selected Sperm Injection
                               7.2.1.1.1 Imsi is Highly Recommended in Patients With A Low Sperm Count and Recurrent Implantation Failure
                    7.2.1.2 Gamete Donation
                               7.2.1.2.1 Increase in the Number of Women Registering as Egg Donors is A Key Factor Aiding Market Growth
           7.2.2 Intracytoplasmic Sperm Injection
                    7.2.2.1 Icsi is A Specialized Form of IVF Involving Fertilization Used Commonly in Male Infertility Treatment Procedures
           7.2.3 Surrogacy
                    7.2.3.1 High Success Rates Guaranteed and Achieved With the Help of Surrogacy are Driving Market Growth
    7.3 Artificial Insemination
           7.3.1 Intrauterine Insemination
                    7.3.1.1 Limited Risk of Complications During Pregnancy and High Success Rates Driving Market Demand for Iui Procedures
           7.3.2 Intracervical Insemination
                    7.3.2.1 Low Cost of Procedure as Compared to Other AI Procedures Leading to Increased Adoption
           7.3.3 Intratubal Insemination
                    7.3.3.1 Better Chances of Successful Pregnancies Using Iti to Drive the Demand for This Procedure
    7.4 Fertility Surgery
           7.4.1 Laparoscopy
                    7.4.1.1 Laparoscopy Allows for the Biopsy of Suspect Growths and Cysts That Hamper Fertility
           7.4.2 Hysteroscopy
                    7.4.2.1 Growing Demand for Minimally Invasive Procedures Driving the Adoption of Hysteroscopy Infertility Treatment Surgeries Globally
           7.4.3 Myomectomy
                    7.4.3.1 Advantages of Myomectomy in Alleviating Problems Caused Due to Fibroids While Preserving Future Fertility to Drive the Demand for This Surgery
           7.4.4 Laparotomy
                    7.4.4.1 Laparotomy is Used in Common Infertility Surgeries That Require Large Exposure to the Reproductive System
           7.4.5 Tubal Ligation Reversal
                    7.4.5.1 Tubal Ligation Reversal is Performed Only in Women Who Still Have A Large Portion of Healthy Fallopian Tube Remaining
           7.4.6 Varicocelectomy
                    7.4.6.1 Adoption of Varicocelectomy is High Among Patients and Results in A High Chance of Improved Fertility With Reduced Complications
           7.4.7 Microsurgical Reconstruction
                    7.4.7.1 Vasovasostomy
                               7.4.7.1.1 Vasovasostomy is A Reversal Surgery Commonly Used in the Treatment of Infertility in Men
                    7.4.7.2 Vasoepididymostomy
                               7.4.7.2.1 Vasoepididymostomy Provides A Higher Pregnancy Rate Than IVF With Icsi
    7.5 Other Infertility Treatment Procedures

8 Infertility Treatment Market, By Patient Type (Page No. - 80)
    8.1 Introduction
    8.2 Female Infertility Treatment
           8.2.1 Increasing Female Infertility Rates to Drive the Growth of the Female Infertility Treatment Market
    8.3 Male Infertility Treatment
           8.3.1 Growing Adoption of Male Infertility Treatment Procedures to Provide Potential Growth Opportunities

9 Infertility Treatment Market, By End User (Page No. - 84)
    9.1 Introduction
    9.2 Fertility Centers
           9.2.1 Growing Number of Infertility Treatment Centers Worldwide Driving Growth of This Segment
    9.3 Hospitals and Surgical Clinics
           9.3.1 Initiatives Undertaken By Governments to Increase the Number of Hospitals Equipped to Perform Infertility Treatment Procedures Contributing to Market Growth
    9.4 Research Institutes
           9.4.1 Growing Need for Improving the Clinical Efficacy of Various Infertility Treatment Options Driving Market Growth in Research Institutes
    9.5 Cryobanks
           9.5.1 Increasing Number of Art Procedures Using Donor Sperm and Donor Eggs for Infertility Treatment Driving the Demand for Cryobanks

10 Infertility Treatment Market, By Region (Page No. - 91)
     10.1 Introduction
     10.2 North America
             10.2.1 Us
                        10.2.1.1 US to Dominate the Infertility Treatment Market in North America
             10.2.2 Canada
                        10.2.2.1 Government Initiatives and Legislations for Same-Sex Marriages to Drive Market Growth in Canada
     10.3 Europe
             10.3.1 Germany
                        10.3.1.1 Favorable Funding Scenario for IVF Treatments in Germany to Drive the Growth of the Infertility Treatment Market in the Country
             10.3.2 Uk
                        10.3.2.1 Increase in the Number of IVF Cycles in the UK Contributing to Market Growth
             10.3.3 France
                        10.3.3.1 The Art Segment Dominated the Infertility Treatment Procedures Market in France
             10.3.4 Rest of Europe
     10.4 Asia Pacific
             10.4.1 Japan
                        10.4.1.1 Growing Awareness has Served to Boost the Adoption of IVF Procedures in Japan
             10.4.2 China
                        10.4.2.1 Declining Newborn Population and Birth Rate in China to Drive the Demand for Infertility Treatment Procedures in the Country
             10.4.3 India
                        10.4.3.1 Rising Fertility Medical Tourism Offering High-Growth Opportunities for the Infertility Treatment Market in India
             10.4.4 Rest of Asia Pacific
     10.5 Rest of the World
             10.5.1 Latin America
                        10.5.1.1 Latin America to Account for the Largest Share of the Rest of the World Infertility Treatment Market
             10.5.2 Middle East & Africa
                        10.5.2.1 Rising Incidence of Male-Factor Infertility to Drive Market Growth During the Forecast Period

11 Competitive Landscape (Page No. - 131)
     11.1 Overview
     11.2 Infertility Treatment: Market Share Analysis, 2017
     11.3 Competitive Scenario

12 Company Profiles (Page No. - 135)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     12.1 Cook Group Incorporated
     12.2 Esco Micro Pte. Ltd.
     12.3 Genea Limited
     12.4 Hamilton Throne, Ltd.
     12.5 Ihmedical A/S
     12.6 Irvine Scientific (A Member of Jx Holdings Group)
     12.7 IVFTech Aps
     12.8 Kitazato Corporation
     12.9 Medgyn Products, Inc.
     12.10 Rocket Medical PLC
     12.11 Somatex Medical Technologies GmbH
     12.12 The Baker Company, Inc.
     12.13 The Cooper Companies, Inc.
     12.14 Thermo Fisher Scientific
     12.15 Vitrolife Ab
     12.16 Zeiss Group

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 168)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Available Customizations
     13.4 Related Reports
     13.5 Author Details


List of Tables (106 Tables)

Table 1 Infertility Treatment Market, By Product, 2016–2023 (USD Million)
Table 2 Infertility Treatment Equipment Market, By Type, 2016–2023 (USD Million)
Table 3 Infertility Treatment Equipment Market, By Region, 2016–2023 (USD Million)
Table 4 Microscopes Market, By Region, 2016–2023 (USD Million)
Table 5 Imaging Systems Market, By Region, 2016–2023 (USD Million)
Table 6 Sperm Analyzer Systems Market, By Region, 2016–2023 (USD Million)
Table 7 Ovum Aspiration Pumps Market, By Region, 2016–2023 (USD Million)
Table 8 Micromanipulator Systems Market, By Region, 2016–2023 (USD Million)
Table 9 Incubators Market, By Region, 2016–2023 (USD Million)
Table 10 Gas Analyzers Market, By Region, 2016–2023 (USD Million)
Table 11 Laser Systems Market, By Region, 2016–2023 (USD Million)
Table 12 Cryosystems Market, By Region, 2016–2023 (USD Million)
Table 13 Media & Consumables Market, By Region, 2016–2023 (USD Million)
Table 14 Accessories Market, By Region, 2016–2023 (USD Million)
Table 15 Infertility Treatment Market, By Procedure, 2016-2023 (USD Million)
Table 16 Assisted Reproductive Technology Market, By Type, 2016–2023 (USD Million)
Table 17 Assisted Reproductive Technology Market, By Region, 2016–2023 (USD Million)
Table 18 in Vitro Fertilization Market, By Region, 2016–2023 (USD Million)
Table 19 Intracytoplasmic Sperm Injection Market, By Region, 2016–2023 (USD Million)
Table 20 Surrogacy Market, By Region, 2016–2023 (USD Million)
Table 21 Artificial Insemination Market, By Type, 2016–2023 (USD Million)
Table 22 Artificial Insemination Market, By Region, 2016–2023 (USD Million)
Table 23 Fertility Surgery Market, By Type, 2016–2023 (USD Million)
Table 24 Fertility Surgery Market, By Region, 2016–2023 (USD Million)
Table 25 Other Infertility Treatment Procedures Market, By Region, 2016–2023 (USD Million)
Table 26 Infertility Treatment Market, By Patient Type, 2016–2023 (USD Million)
Table 27 Female Infertility Treatment Market, By Region, 2016–2023 (USD Million)
Table 28 Male Infertility Treatment Market, By Region, 2016–2023 (USD Million)
Table 29 Market, By End User, 2016–2023 (USD Million)
Table 30 Market for Fertility Clinics, By Region, 2016–2023 (USD Million)
Table 31 Infertility Treatment Devices Market for Hospitals and Surgical Clinics, By Region, 2016–2023 (USD Million)
Table 32 Market for Research Institutes, By Region, 2016–2023 (USD Million)
Table 33 Market for Cryobanks, By Region, 2016–2023 (USD Million)
Table 34 Market, By Region, 2016–2023 (USD Million)
Table 35 North America: Infertility Treatment Market, By Country, 2016–2023 (USD Million)
Table 36 North America: Market, By Procedure, 2016–2023 (USD Million)
Table 37 North America: Market, By Product, 2016–2023 (USD Million)
Table 38 North America: Market, By Patient Type, 2016–2023 (USD Million)
Table 39 North America: Market, By End User, 2016–2023 (USD Million)
Table 40 US: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 41 US: Market, By Product, 2016–2023 (USD Million)
Table 42 US: Market, By End User, 2016–2023 (USD Million)
Table 43 US: Market, By Patient Type, 2016–2023 (USD Million)
Table 44 Canada: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 45 Canada: Market, By Product, 2016–2023 (USD Million)
Table 46 Canada: Market, By End User, 2016–2023 (USD Million)
Table 47 Canada: Market, By Patient Type, 2016–2023 (USD Million)
Table 48 Europe: Infertility Treatment Market, By Country, 2016–2023 (USD Million)
Table 49 Europe: Market, By Procedure, 2016–2023 (USD Million)
Table 50 Europe: Market, By Product, 2016–2023 (USD Million)
Table 51 Europe: Market, By Patient Type, 2016–2023 (USD Million)
Table 52 Europe: Market, By End User, 2016–2023 (USD Million)
Table 53 Germany: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 54 Germany: Market, By Product, 2016–2023 (USD Million)
Table 55 Germany: Market, By Patient Type, 2016–2023 (USD Million)
Table 56 Germany: Market, By End User, 2016–2023 (USD Million)
Table 57 UK: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 58 UK: Market, By Product, 2016–2023 (USD Million)
Table 59 UK: Market, By Patient Type, 2016–2023 (USD Million)
Table 60 UK: Market, By End User, 2016–2023 (USD Million)
Table 61 France: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 62 France: Market, By Product, 2016–2023 (USD Million)
Table 63 France: Market, By Patient Type, 2016–2023 (USD Million)
Table 64 France: Market, By End User, 2016–2023 (USD Million)
Table 65 RoE: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 66 RoE: Market, By Product, 2016–2023 (USD Million)
Table 67 RoE: Market, By End User, 2016–2023 (USD Million)
Table 68 RoE: Market, By Patient Type, 2016–2023 (USD Million)
Table 69 APAC: Infertility Treatment Market, By Country, 2016–2023 (USD Million)
Table 70 APAC: Market, By Procedure, 2016–2023 (USD Million)
Table 71 APAC: Market, By Product, 2016–2023 (USD Million)
Table 72 APAC: Market, By Patient Type, 2016–2023 (USD Million)
Table 73 APAC: Market, By End User, 2016–2023 (USD Million)
Table 74 Japan: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 75 Japan: Market, By Product, 2016–2023 (USD Million)
Table 76 Japan: Market, By Patient Type, 2016–2023 (USD Million)
Table 77 Japan: Market, By End User, 2016–2023 (USD Million)
Table 78 China: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 79 China: Market, By Product, 2016–2023 (USD Million)
Table 80 China: Market, By Patient Type, 2016–2023 (USD Million)
Table 81 China: Market, By End User, 2016–2023 (USD Million)
Table 82 India: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 83 India: Market, By Product, 2016–2023 (USD Million)
Table 84 India: Market, By Patient Type, 2016–2023 (USD Million)
Table 85 India: Market, By End User, 2016–2023 (USD Million)
Table 86 RoAPAC: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 87 RoAPAC: Market, By Product, 2016–2023 (USD Million)
Table 88 RoAPAC: Market, By Patient Type, 2016–2023 (USD Million)
Table 89 RoAPAC: Market, By End User, 2016–2023 (USD Million)
Table 90 RoW: Infertility Treatment Market, By Country, 2016–2023 (USD Million)
Table 91 RoW: Market, By Procedure, 2016–2023 (USD Million)
Table 92 RoW: Market, By Product, 2016–2023 (USD Million)
Table 93 RoW: Market, By Patient Type, 2016–2023 (USD Million)
Table 94 RoW: Market, By End User, 2016–2023 (USD Million)
Table 95 Latin America: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 96 Latin America: Market, By Product, 2016–2023 (USD Million)
Table 97 Latin America: Market, By Patient Type, 2016–2023 (USD Million)
Table 98 Latin America: Market, By End User, 2016–2023 (USD Million)
Table 99 Middle East & Africa: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 100 Middle East & Africa: Market, By Product, 2016–2023 (USD Million)
Table 101 Middle East & Africa: Market, By Patient Type, 2016–2023 (USD Million)
Table 102 Middle East & Africa: Market, By End User, 2016–2023 (USD Million)
Table 103 Product Launches and Enhancements
Table 104 Expansions
Table 105 Collaborations, Partnerships, and Agreements
Table 106 Acquisitions


List of Figures (32 Figures)

Figure 1 Infertility Treatment Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Bottom-Up Approach Market Size Estimation: Infertility Treatment Market
Figure 4 Top-Down Approach Market Size Estimation: Infertility Treatment Market
Figure 5 Data Triangulation Methodology
Figure 6 Infertility Treatment Market, By Procedure, 2018 vs 2023 (USD Million)
Figure 7 Market Share, By Product, 2018
Figure 8 Market Share, By Patient Type, 2018
Figure 9 Market, By End User, 2018 vs 2023 (USD Million)
Figure 10 Geographic Snapshot of the Infertility Treatment Market
Figure 11 Declining Global Fertility Rate—Major Factor Driving Market Growth
Figure 12 Media & Consumables Market in the Asia Pacific to Register the Highest Growth Rate During the Forecast Period
Figure 13 Assisted Reproductive Technology Segment to Dominate the Asia Pacific Infertility Treatment Market in 2018
Figure 14 Female Infertility Treatment Segment Will Continue to Dominate the Global Market in 2023
Figure 15 Fertility Centers to Dominate the Infertility Treatment Market During the Forecast Period
Figure 16 Asia Pacific to Register the Highest Growth in the Forecast Period
Figure 17 Global Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Declining Global Fertility Rate (1960–2016)
Figure 19 Global Market, By Product, 2018 vs 2023 (USD Million)
Figure 20 Global Market, By Procedure, 2018 vs 2023 (USD Million)
Figure 21 Female Infertility Treatment Segment to Dominate the Market During the Forecast Period
Figure 22 Global Market, By End User, 2018 vs 2023 (USD Million)
Figure 23 Global Market, By Region, 2018 vs 2023 (USD Million)
Figure 24 North America: Infertility Treatment Market Snapshot
Figure 25 Europe: Infertility Treatment Market Snapshot
Figure 26 Asia Pacific: Infertility Treatment Market Snapshot
Figure 27 The Cooper Companies Held the Leading Position in the Infertility Treatment Market, 2017
Figure 28 Hamilton Throne Ltd.: Company Snapshot
Figure 29 The Cooper Companies: Company Snapshot
Figure 30 Thermo Fisher Scientific: Company Snapshot
Figure 31 Vitrolife: Company Snapshot
Figure 32 Zeiss Group: Company Snapshot


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 3765
Published ON
Nov, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Infertility Treatment Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved